Universal-Beteiligungs- und Servicegesellschaft
CLDX icon

Universal-Beteiligungs- und Servicegesellschaft’s Celldex Therapeutics CLDX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
70,053
+37,790
+117% +$1.03M ﹤0.01% 1202
2025
Q4 		$876K Buy
32,263
+12,966
+67% +$342K ﹤0.01% 1534
2025
Q3 		$499K Buy
19,297
+2,802
+17% +$64.9K ﹤0.01% 1746
2025
Q2 		$336K Buy
16,495
+1,661
+11% +$32.3K ﹤0.01% 1798
2025
Q1 		$269K Buy
+14,834
New +$331K ﹤0.01% 1813

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return